Product Search |
|
Input Product Name Or Cas No. |
Category |
Products |
di-p-tolylmethanol |
Methacryloylmorpholine |
N2-Methyl-N1,N1-bis[2-(methylamino)ethyl |
2-Methylenecyclohexanone |
Phenol, 2,6-dimethyl-, 1-acetate |
2,2,6,6-Tetramethyl-4-(2-oxiranylmethoxy |
2-Methylenecyclopentanone |
1-Ethenyl-4-(2-propen-1-yl)benzene |
N1-Methyl-N2-[2-(methylamino)ethyl]-1,2- |
Methyl 4-cyano-4-[[(dodecylthio)thioxome |
3-Cyano-2,2,5,5-tetramethyl-1-pyrrolidin |
3-Ethenyldihydro-2,5-furandione |
Ethyl 2-cycloheptylideneacetate |
2-Hydroxy-3-(2-propen-1-yloxy)propyl 2-m |
Solerole |
4-Ethenyl-2-fluoro-1-methoxybenzene |
Dihydro-3-iodo-2(3H)-furanone |
2,2,2-trifluoroethyl 2-fluoroacrylate |
3-(adamantan-1-yl)propan-1-ol |
1-(adamantan-1-yl)-1H-pyrrole-2,5-dione |
cyclohexyl 2-bromopropanoate |
2,2,2-trifluoroethyl 2-chloroacrylate |
2,2-Dimethyl-5-methylene-1,3-dioxane-4,6 |
Methanesulfonic acid, 2-(dimethylamino)e |
Dihydro-5-methyl-3-methylene-5-phenyl-2( |
1-Chlorocyclohexanecarbonyl chloride |
2,2′-(1,2-Diazenediyl)bis[N-[1-(hydrox |
1,1-difluoro-2-phenylpropan-2-ol |
1-Hydroxycyclopentanepropanol |
1-Methyl-3-methylene-2,5-pyrrolidinedion |
ethyl 4,4,5,5,5-pentafluoro-3-hydroxypen |
1-(2-oxo-2-phenylethyl)tetrahydro-1H-thi |
1,1,1-trifluoro-3,3-bis(fluorosulfonyl)p |
Bis(4-fluorophenyl)iodonium |
adamantan-1-yl(cyclohexyl)methanone |
2,2-difluoroethyl methacrylate |
1,2-di(1,4-dioxaspiro[4.5]decan-2-yl)eth |
5-(2-Bromo-1,1,2,2-tetrafluoroethyl)bicy |
1,4-Dithiane-2-methanol |
4-(Methylsulfonyl)thiomorpholine |
4,5-Dimethyl-4-hexenoic acid |
1,1′-(Dithiodicarbonothioyl)bis[1H-pyr |
2-(tert-butoxy)ethyl methacrylate |
α1,α1,α3,α3-Tetramethyl-5-(1-methyle |
1,3-Dimethyl 5-amino-2,4,6-triiodo-1,3-b |
4-Oxopentyl 2-methyl-2-propenoate |
1-Ethylcyclobutanol |
2-((2-hydroxyethyl)thio)ethyl methacryla |
1-Methylcyclopentyl 2-bromoacetate |
2,2,3,3,3-Pentafluoropropyl 2-bromoaceta |
|
Products |
Catalogue Number |
Products |
CAS No. |
Assay |
Rovathin001 | 2-Chloro-4,6-dimethylpyridine | 30838-93-8 | 97% |
Rovathin002 | 2-bromo-4,6-dimethylpyridine | 4926-26-5 | 97% |
Rovathin003 | 2-(6-Chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate | 330645-87-9 | 98% |
Rovathin004 | tert-Butyldimethylchlorosilane | 18162-48-6 | 98% |
Rovathin005 | 1,3-Diphenylisobenzofuran | 5471-63-6 | 97% |
Rovathin006 | Perindopril erbumine | 107133-36-8 | 97% |
Rovathin007 | 9-[4-Acetoxy-3-(acetoxymethyl)butyl]-2-amino-6-chloropurine | 97845-60-8 | 98% |
Rovathin008 | Pyrimidine-5-boronic acid | 109299-78-7 | 97% |
Rovathin009 | 2-Chloro-3-nitro-4-picoline | 23056-39-5 | 97% |
Rovathin010 | 7-Azaindole | 271-63-6 | 97% |
Rovathin011 | 4-Azaindole | 272-49-1 | 97% |
Rovathin012 | 5-Azaindole | 271-34-1 | 97% |
Rovathin013 | 6-Azaindole | 271-29-4 | 97% |
Rovathin014 | 7-azaoxindole | 5654-97-7 | 96% |
Rovathin015 | 6-azaoxindole | 54415-85-9 | 96% |
Rovathin016 | 4-tert-Butylphenylboronic acid | 123324-71-0 | 98% |
Rovathin017 | D-Galactosamine hydrochloride | 1772-03-8 | 97% min |
Rovathin018 | N-Acetyl-D-galactosamine | 1811-31-0/14215-68-0 | 97% min |
Rovathin019 | Acetobromo-alpha-D-glucose | 572-09-8 | 95% |
Rovathin020 | Risperidone | 106266-06-2 | EP |
Rovathin021 | N-Trifluoroacetyl-L-lysine | 10009-20-8 | 97% |
Rovathin022 | Benzenebutanoic acid, a-[[1-carboxy-5-[(trifluoroacetyl)amino]pentyl]amino]-, monoethyl ester, [S-(R*,R*)]- (9CI) | 116169-90-5 | 97% |
Rovathin023 | N2-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-N6-trifluoroacetyl-L-lysyl-L-proline | 103300-91-0 | 97% |
Rovathin024 | 3-Aminocarbonylphenylboronic acid | 351422-73-6 | 97% |
Rovathin025 | 2,4-Dichloro-6-methylpyrimidine | 5424-21-5 | 98% |
Rovathin026 | N-(4-Aminobutyl)-N-ethylisoluminol | 66612-29-1 | 90% |
Rovathin027 | 7-Azabenzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate | 156311-85-2 | 98% |
Rovathin028 | Benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate | 56602-33-6 | 98% |
Rovathin029 | 4,4'-Dimethoxytriphenylmethyl chloride | 40615-36-9 | 97% |
Rovathin030 | 2-Chloro-1-methylpyridinium iodide | 14338-32-0 | 97% |
|
|
|
|